Skip to main content
Erschienen in: World Journal of Surgery 7/2014

01.07.2014

Preoperative MRI of the Breast (POMB) Influences Primary Treatment in Breast Cancer: A Prospective, Randomized, Multicenter Study

verfasst von: Virginia Gonzalez, Kerstin Sandelin, Anders Karlsson, Wiveca Åberg, Lars Löfgren, Gabriela Iliescu, Staffan Eriksson, Brita Arver

Erschienen in: World Journal of Surgery | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Breast magnetic resonance imaging (MRI) has shown high sensitivity in determining tumor extent, multifocality, and occult contralateral breast cancer. Low specificity, unnecessary mastectomies, and costs are arguments against MRI. The purpose of this study was to determine whether preoperative breast MRI would affect primary surgical management, reduce reexcision/reoperation procedures, and influence the choice of neoadjuvant treatment in patients with newly diagnosed breast cancer.

Methods

This prospective, randomized, multicenter study included 440 breast cancer patients younger than aged 56 years from three, Swedish, large-volume breast units. Patients were randomly allocated on a 1:1 basis to either preoperative staging with breast MRI (n = 220) or no breast MRI (n = 220) (control group). Treatment planning of all patients was discussed at multidisciplinary team conferences.

Results

In patients randomized to the MRI group, who had an observed higher percentage of planned breast-conserving surgery (BCS) compared with the control group, a change from suggested breast conservation to mastectomy occurred in 23 of 153 (15 %) patients. Breast MRI provided additional information in 83 of 220 (38 %) patients, which caused a change in treatment plan in 40 (18 %). The breast reoperation rate was significantly lower in the MRI group: 11 of 220 (5 %) versus 33 of 220 (15 %) in the control group (p < 0.001). The number of mastectomies, axillary reoperations, and the number of patients receiving neoadjuvant chemotherapy after definitive treatment did not differ significantly between the groups.

Conclusions

Preoperative staging with breast MRI in women younger than age 56 years altered the treatment plan in 18 % of the patients. Although a higher MRI-related conversion rate from breast conservation to mastectomy was found, the final numbers of mastectomies did not differ between the two groups. The breast reoperation rate in the MRI group was significantly reduced.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Drew P, Turnbull L, Chatterjee S et al (1999) Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesion. Ann Surg 230(5):680PubMedCentralPubMedCrossRef Drew P, Turnbull L, Chatterjee S et al (1999) Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesion. Ann Surg 230(5):680PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Rodenko GN, Harms SE, Pruneda JM et al (1996) MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. Am J Roentgenol 167(6):1415–1419CrossRef Rodenko GN, Harms SE, Pruneda JM et al (1996) MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. Am J Roentgenol 167(6):1415–1419CrossRef
3.
Zurück zum Zitat Carney P, Miglioretti D, Bonnie C et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168–175PubMedCrossRef Carney P, Miglioretti D, Bonnie C et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168–175PubMedCrossRef
4.
Zurück zum Zitat Van Goethem M, Tjalma W, Schelfout K et al (2006) Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 32(9):901–910PubMedCrossRef Van Goethem M, Tjalma W, Schelfout K et al (2006) Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 32(9):901–910PubMedCrossRef
5.
Zurück zum Zitat Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology 233:830–849PubMedCrossRef Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology 233:830–849PubMedCrossRef
6.
Zurück zum Zitat Plevritis SK, Kurian AW, Sigal BM et al (2006) Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295(20):2374–2384PubMedCrossRef Plevritis SK, Kurian AW, Sigal BM et al (2006) Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295(20):2374–2384PubMedCrossRef
7.
Zurück zum Zitat Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89PubMedCrossRef Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89PubMedCrossRef
8.
Zurück zum Zitat Atkins JJ, Appleton CM, Fisher CS et al (2013) Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer? J Oncol 2013:964863PubMedCentralPubMedCrossRef Atkins JJ, Appleton CM, Fisher CS et al (2013) Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer? J Oncol 2013:964863PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer meta-analysis of surgical outcomes. Ann Surg 257:249–255PubMedCrossRef Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer meta-analysis of surgical outcomes. Ann Surg 257:249–255PubMedCrossRef
10.
Zurück zum Zitat Checka CM, Chun JE, Schnabel FR et al (2012) The relationship of mammographic density and age: implication for breast cancer screening. Am J Roentgenol 198(3):292–295CrossRef Checka CM, Chun JE, Schnabel FR et al (2012) The relationship of mammographic density and age: implication for breast cancer screening. Am J Roentgenol 198(3):292–295CrossRef
11.
Zurück zum Zitat Wolfe JN, Albert S, Belle S et al (1983) Brest parenchymal patterns and their relationship to risk for having or developing carcinoma. Radiol Clin North Am 21:127–136PubMed Wolfe JN, Albert S, Belle S et al (1983) Brest parenchymal patterns and their relationship to risk for having or developing carcinoma. Radiol Clin North Am 21:127–136PubMed
13.
Zurück zum Zitat Bergkvist L, Frisell J, Swedish Breast Cancer Group, Swedish Society of Breast Surgeons (2005) Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 92(10):1221–1224PubMedCrossRef Bergkvist L, Frisell J, Swedish Breast Cancer Group, Swedish Society of Breast Surgeons (2005) Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 92(10):1221–1224PubMedCrossRef
14.
Zurück zum Zitat Andersson Y, Frisell J, Sylvan M et al (2013) Causes of false-negative sentinel node biopsy in patients with breast cancer. Br J Surg 100(6):775–783PubMedCrossRef Andersson Y, Frisell J, Sylvan M et al (2013) Causes of false-negative sentinel node biopsy in patients with breast cancer. Br J Surg 100(6):775–783PubMedCrossRef
16.
Zurück zum Zitat Bedrosian I, Mick R, Orel SG et al (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98(3):468–473PubMedCrossRef Bedrosian I, Mick R, Orel SG et al (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98(3):468–473PubMedCrossRef
17.
Zurück zum Zitat Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571PubMedCrossRef Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571PubMedCrossRef
18.
Zurück zum Zitat Peters NH, van Esser S, van den Bosch MA et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—randomised controlled trial. Eur J Cancer 47(6):879–886PubMedCrossRef Peters NH, van Esser S, van den Bosch MA et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—randomised controlled trial. Eur J Cancer 47(6):879–886PubMedCrossRef
19.
Zurück zum Zitat Kuhl C, Kuhn W, Braun M et al (2007) Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast 16:S34–S44PubMedCrossRef Kuhl C, Kuhn W, Braun M et al (2007) Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast 16:S34–S44PubMedCrossRef
Metadaten
Titel
Preoperative MRI of the Breast (POMB) Influences Primary Treatment in Breast Cancer: A Prospective, Randomized, Multicenter Study
verfasst von
Virginia Gonzalez
Kerstin Sandelin
Anders Karlsson
Wiveca Åberg
Lars Löfgren
Gabriela Iliescu
Staffan Eriksson
Brita Arver
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 7/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-014-2605-0

Weitere Artikel der Ausgabe 7/2014

World Journal of Surgery 7/2014 Zur Ausgabe

Best Paper at Breast Surgery International Congress, ISW, Helsinki, Finland, August 2013

Time to Breast Cancer Relapse Predicted By Primary Tumour Characteristics, Not Lymph Node Involvement

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.